U.S. Markets open in 3 hrs 52 mins
  • S&P Futures

    4,464.33
    -9.92 (-0.22%)
     
  • Dow Futures

    34,696.80
    -52.20 (-0.15%)
     
  • Nasdaq Futures

    15,486.67
    -31.08 (-0.20%)
     
  • Russell 2000 Futures

    2,241.04
    +7.84 (+0.35%)
     
  • Crude Oil

    70.60
    -1.37 (-1.90%)
     
  • Gold

    1,757.60
    +6.20 (+0.35%)
     
  • Silver

    22.38
    +0.08 (+0.36%)
     
  • EUR/USD

    1.1710
    -0.0022 (-0.1873%)
     
  • 10-Yr Bond

    1.3700
    0.0000 (0.00%)
     
  • Vix

    25.26
    +6.57 (+35.15%)
     
  • GBP/USD

    1.3676
    -0.0062 (-0.4499%)
     
  • USD/JPY

    109.6860
    -0.2090 (-0.1902%)
     
  • BTC-USD

    45,003.47
    -3,072.12 (-6.39%)
     
  • CMC Crypto 200

    1,124.29
    -101.24 (-8.26%)
     
  • FTSE 100

    6,848.10
    -115.54 (-1.66%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

Global Intravascular Ultrasound Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

·4 min read

DUBLIN, September 06, 2021--(BUSINESS WIRE)--The "Intravascular Ultrasound (IVUS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Intravascular Ultrasound (IVUS) estimated at US$586.5 Million in the year 2020, is projected to reach a revised size of US$794.2 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.

IVUS Catheters, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$453.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the IVUS Consoles segment is readjusted to a revised 3.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $158 Million, While China is Forecast to Grow at 8% CAGR

The Intravascular Ultrasound (IVUS) market in the U.S. is estimated at US$158 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$174.7 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Other Segments Segment to Record 3% CAGR

In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 2.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$52.1 Million in the year 2020 will reach a projected size of US$62.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$113.7 Million by the year 2027, while Latin America will expand at a 3.9% CAGR through the analysis period.

Select Competitors (Total 90 Featured):

  • Allergan plc

  • AstraZeneca

  • Bayer HealthCare Pharmaceuticals

  • Biogen, Inc.

  • GlaxoSmithKline Plc

  • H. Lundbeck A/S

  • Johnson & Johnson

  • Novartis AG

  • Parion Sciences, Inc.

  • Pfizer Inc.

  • Sanofi S.A.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Intravascular Ultrasound (IVUS) - High Potential in Interventional Cardiology

  • Growth Drivers

  • Growth Restraints/Key Challenges

  • Recent Market Activity

  • US and Japan Take the Lead, Developing Countries Spearhead Growth

  • IVUS Catheters Remain the Key Revenue Spinners

  • Key Players

  • Select Approved IVUS Catheters in the Market

  • Coronary Artery - The Leading Target Area for IVUS

  • IVUS Addresses Growing Need for Minimally Invasive Procedures

  • Stents Transform CAD Treatment, IVUS Expands Efficacy

  • Superior Capabilities over Angiography Propels IVUS Adoption

  • Strong Clinical Evidence and Technological Improvements Support IVUS Sales

  • Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT)

  • Clinical Studies Critical in Encouraging Physicians to Take Up IVUS

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Boston Scientific Corporation (USA)

  • InfraredxT, Inc. (USA)

  • Koninklijke Philips N.V. (Royal Philips) - The Netherlands

  • Terumo Corp. (Japan)

3. MARKET TRENDS & DRIVERS

  • Are Integrated Systems the Future of IVUS?

  • IVUS-OCT and Other Multi-Modality Imaging Systems

  • Advanced Hybrid Imaging Modalities-Thing of the Future

  • Integrated IVUS Consoles Enhance Workflow

  • Virtual Histology Perceived to Improve IVUS Image Assessment; However, Clinical Trials Lacking

  • Advanced IVUS Catheter Transducer Technology

  • Capacitive Micromachined Ultrasonic Transducers (cMUT) Capture Manufacturers' Attention

  • Motorized or Manual Transducer Pullback

  • FL-IVUS - Expanding Indications of IVUS

  • New Launches/Innovations

  • Global Menace of Cardiovascular Disease (CVD) - A Major Growth Driver

  • Aging Population: A Strong Growth Driver

  • Increase in Healthcare Spending to Drive Growth

  • Risk of CAD in Obesity Offers Prospects for IVUS Devices

  • Diabetics at Higher Risk of Heart Diseases

  • IVUS Imaging Aids Physicians in Filing Documentation for Reimbursement Claims

  • Staff Training Vital for Realizing True Potential of IVUS in Catheterization Labs

  • Software Component Adds Further Assessment Capabilities

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/fld781

View source version on businesswire.com: https://www.businesswire.com/news/home/20210906005250/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900